Free Trial

Digital Health Acquisition (DHAC) Competitors

Digital Health Acquisition logo
$1.32 -0.02 (-1.49%)
As of 07/30/2025

DHAC vs. BGLC, BRTX, MGRX, SSY, ACON, ATIP, OTRK, NIVF, OPGN, and BACK

Should you be buying Digital Health Acquisition stock or one of its competitors? The main competitors of Digital Health Acquisition include BioNexus Gene Lab (BGLC), Biorestorative Therapies (BRTX), Mangoceuticals (MGRX), SunLink Health Systems (SSY), Aclarion (ACON), ATI Physical Therapy (ATIP), Ontrak (OTRK), NewGenIvf Group (NIVF), OpGen (OPGN), and IMAC (BACK). These companies are all part of the "healthcare" industry.

Digital Health Acquisition vs. Its Competitors

BioNexus Gene Lab (NASDAQ:BGLC) and Digital Health Acquisition (NASDAQ:DHAC) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, risk, earnings, profitability, media sentiment, valuation and analyst recommendations.

In the previous week, BioNexus Gene Lab had 4 more articles in the media than Digital Health Acquisition. MarketBeat recorded 4 mentions for BioNexus Gene Lab and 0 mentions for Digital Health Acquisition. Digital Health Acquisition's average media sentiment score of 0.05 beat BioNexus Gene Lab's score of 0.04 indicating that Digital Health Acquisition is being referred to more favorably in the news media.

Company Overall Sentiment
BioNexus Gene Lab Neutral
Digital Health Acquisition Neutral

18.9% of BioNexus Gene Lab shares are held by institutional investors. Comparatively, 1.0% of Digital Health Acquisition shares are held by institutional investors. 0.7% of BioNexus Gene Lab shares are held by insiders. Comparatively, 6.6% of Digital Health Acquisition shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Digital Health Acquisition has a net margin of 0.00% compared to BioNexus Gene Lab's net margin of -22.85%. Digital Health Acquisition's return on equity of 0.00% beat BioNexus Gene Lab's return on equity.

Company Net Margins Return on Equity Return on Assets
BioNexus Gene Lab-22.85% -24.18% -20.14%
Digital Health Acquisition N/A N/A N/A

Digital Health Acquisition has lower revenue, but higher earnings than BioNexus Gene Lab.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioNexus Gene Lab$9.51M1.22-$1.60MN/AN/A
Digital Health AcquisitionN/AN/AN/AN/AN/A

BioNexus Gene Lab has a beta of 5.31, suggesting that its share price is 431% more volatile than the S&P 500. Comparatively, Digital Health Acquisition has a beta of 0.23, suggesting that its share price is 77% less volatile than the S&P 500.

Summary

Digital Health Acquisition beats BioNexus Gene Lab on 5 of the 9 factors compared between the two stocks.

Get Digital Health Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for DHAC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DHAC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DHAC vs. The Competition

MetricDigital Health AcquisitionHolding Offices IndustryServices SectorNASDAQ Exchange
Market Cap$4.76M$212.91M$293.49M$9.53B
Dividend YieldN/A3.27%2.29%4.08%
P/E RatioN/A1.928.7123.80
Price / SalesN/A560.254.3188.08
Price / CashN/A115.774.9457.96
Price / BookN/A8.972.505.55
Net IncomeN/A-$11.33M-$19.24M$259.03M
7 Day Performance-0.75%-1.46%-10.02%-4.56%
1 Month Performance10.00%-1.34%7.25%4.49%
1 Year Performance-68.94%115.95%243.83%18.05%

Digital Health Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DHAC
Digital Health Acquisition
N/A$1.32
-1.5%
N/A-43.8%$4.76MN/A0.002,021Gap Down
BGLC
BioNexus Gene Lab
0.3115 of 5 stars
$6.93
-3.5%
N/A+43.2%$12.90M$9.27M0.0030News Coverage
Short Interest ↑
Gap Down
BRTX
Biorestorative Therapies
3.5034 of 5 stars
$1.47
-0.7%
$18.00
+1,124.5%
-7.8%$11.11M$400K-1.007
MGRX
Mangoceuticals
N/A$1.68
flat
N/A-98.0%$8.68M$620K-0.363Positive News
Gap Up
SSY
SunLink Health Systems
1.6969 of 5 stars
$1.07
-7.0%
N/A+22.4%$8.10M$31.09M7.641,376Gap Down
ACON
Aclarion
1.464 of 5 stars
$6.95
-2.7%
$11,758.50
+169,087.1%
-99.7%$4.16M$50K0.007
ATIP
ATI Physical Therapy
0.1243 of 5 stars
$0.68
flat
N/A-89.1%$2.98M$741.86M-0.045,600News Coverage
Upcoming Earnings
OTRK
Ontrak
1.8997 of 5 stars
$0.31
-37.2%
$24.00
+7,732.9%
-92.0%$2.06M$10.18M-0.02250Upcoming Earnings
Short Interest ↑
High Trading Volume
NIVF
NewGenIvf Group
N/A$0.44
+3.3%
N/A-99.8%$1.82M$5.43M0.00N/APositive News
Gap Down
OPGN
OpGen
N/A$0.04
flat
N/A-98.7%$396K$2.67M0.00100Positive News
Short Interest ↓
BACK
IMAC
N/A$0.06
flat
N/A-96.1%$124K$72.05K0.00180Upcoming Earnings
Gap Up

Related Companies and Tools


This page (NASDAQ:DHAC) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners